Musters R J, van der Meulen E T, van der Laarse W J, van Hardeveld C
Institute for Cardiovascular Research Vrije Universiteit, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands.
J Mol Cell Cardiol. 1997 May;29(5):1341-54. doi: 10.1006/jmcc.1996.0368.
The present study was designed in order to investigate more precisely the role of calcium homeostasis maintenance in protein kinase C (PKC) mediated preconditioning. We used a 15 min pre-incubation period, with 1 mumol/l exogenous norepinephrine (NE) to pharmacologically precondition isolated, superfused rat trabeculae against contractile dysfunctioning following 120 min of metabolic inhibition (MI, in 2 mmol/l CN- containing Tyrode without glucose at 1 Hz stimulation frequency). Contractile recovery was studied during a subsequent 60 min recovery period (RP, in glucose containing Tyrode at 0.2 Hz). Tyrode was gassed with 95%, O2/ 5% CO2 and kept at a constant temperature of 24 degrees C. Force and intracellular free calcium ([Ca2+]i) were monitored throughout the experimental protocol; [Ca2+]i was measured using fura-2. Pretreatment with NE (group NE-I) significantly increased the fraction of trabeculae that resumed to contract during RP, from 36 +/- 13% (mean +/- S.E.M.) in controls to 82 +/- 10% (P < 0.05). In correspondence with this, NE-pretreatment increased the proportion of trabeculae in which the Ca2+ rise from the onset of rigor development during MI was attenuated. After 40 min of MI [Ca2+]i in the failing control, as well as failing group NE-I, trabeculae (1.08 +/- 0.20 and 1.51 +/- 0.26 mumol/l, respectively) was increased significantly compared to the mean value registered in the recovering preparations of these groups (0.34 +/- 0.04 mumol/l: P < 0.05). Specific inhibition of PKC with 2 mumol/l chelerythrine (group NE-IV) almost completely blocked the protection induced by NE-pretreatment, including its protective action against Ca2+ overload, i.e. the fraction of trabeculae that resumed to contract during RP returned to untreated control level (46 +/- 11%: P < 0.05 v group NE-I). Also in this case [Ca2+]i in the failing group NE-IV trabeculae after 40 min of MI was increased substantially, compared to the value measured in the recovering preparations (4.75 +/- 1.00 and 0.60 +/- 0.08 mumol/ l, respectively). The relative importance of both alpha-adrenergic and beta-adrenergic receptor pathways in this preconditioning-like effect of NE-pretreatment, was investigated using specific blockers. The results point to an alpha 1-adrenergic receptor mediated signaling mechanism, which enhances PKC-dependent control of [Ca2+]i from the onset of rigor development during MI.
本研究旨在更精确地探究钙稳态维持在蛋白激酶C(PKC)介导的预处理中的作用。我们采用15分钟的预孵育期,加入1μmol/L外源性去甲肾上腺素(NE),对分离的、经灌流的大鼠小梁进行药理学预处理,以对抗120分钟代谢抑制(MI,在含2mmol/L氰化物且无葡萄糖的台氏液中,刺激频率为1Hz)后的收缩功能障碍。在随后的60分钟恢复期(RP,在含葡萄糖的台氏液中,刺激频率为0.2Hz)研究收缩恢复情况。台氏液用95%O₂/5%CO₂通气,并保持在24℃的恒定温度。在整个实验过程中监测张力和细胞内游离钙([Ca²⁺]i);使用fura-2测量[Ca²⁺]i。用NE预处理(NE-I组)显著增加了在RP期间恢复收缩的小梁比例,从对照组的平均±标准误36±13%增加到82±10%(P<0.05)。与此相应,NE预处理增加了小梁中Ca²⁺从MI期间强直发生开始时升高减弱的比例。在MI 40分钟后,失败对照组以及失败NE-I组小梁中的[Ca²⁺]i(分别为1.08±0.20和1.51±0.26μmol/L)与这些组恢复准备中的平均值(0.34±0.04μmol/L:P<0.05)相比显著增加。用2μmol/L白屈菜红碱特异性抑制PKC(NE-IV组)几乎完全阻断了NE预处理诱导的保护作用,包括其对Ca²⁺超载的保护作用,即在RP期间恢复收缩的小梁比例恢复到未处理对照组水平(46±11%:与NE-I组相比P<0.05)。同样在这种情况下,与恢复准备中测量的值相比,MI 40分钟后失败NE-IV组小梁中的[Ca²⁺]i也显著增加(分别为4.75±1.00和0.60±0.08μmol/L)。使用特异性阻滞剂研究了α-肾上腺素能和β-肾上腺素能受体途径在NE预处理这种类似预处理效应中的相对重要性。结果表明存在一种α₁-肾上腺素能受体介导的信号机制,其从MI期间强直发生开始增强PKC对[Ca²⁺]i的依赖性控制。